Effects of Selected Doses of Caffeine Following Fasting on Hand Steadiness, Tracing Ability, Kinesthetic Sense and Manual Dexterity by Winter, Krista A.
THE EFFECTS OF SELECTED DOSES OF CAFFEINE 
FOLLOWING FASTING ON HAND STEADINESS, 
TRACING ABILITY, KINESTHETIC 
SENSE AND MANUAL 
DEXTERITY 
By 
KRISTA A. WINTER 
Bachelor of Science 
Oklahoma State University 
Stillwater, Oklahoma 
1988 
Submitted to the Faculty of the 
Graduate College of the 
Oklahoma State University 
in partial fulfillment of 
the requirements for 
the Degree of 
MASTER OF SCIENCE 
December, 1990 
dJvLO--t /._v 
\C(; C> 
L0r-lf3Se 
II ''D '\.,.,~--~ 
Oklahoma State Univ., Library 
THE EFFECTS OF SELECTED DOSES OF CAFFEINE 
FOLLOWING FASTING ON, HAND STEADINESS, 
TRACING ABILITY, KINESTHETIC 
SENSE AND MANUAL 
DEXTERITY 
Thesis Approved: 
ii 
1380875 
ACKNOWLEDGMENTS 
I wish to express my sincere appreciation to Dr. Bert 
Jacobson, head of my graduate committee, for his outstanding 
guidance and intelligence throughout my coursework and 
study. I am also grateful to the other committee members, 
Dr. Sandy Gangstead and Dr. Frank Kulling, for their 
suggestions and support during the course of this study and 
the graduate program. I would also like to thank Dr. Steve 
Edwards for his assistance during the statistical analysis 
phase of this study. ,I wish tp extend my gratitude to the 
subjects who participated in this study. Without them this 
study would not have been possible. 
I wish to extend a special thank you to my fiance, Don 
Roberts, whose moral support and encouragement were always 
the light at the end of the tunnel. A special thank you 
also goes to my parents, Dallas and Mary Lou Winter, for the 
inspiration they have given me. Their encouragement and 
never ending aid has helped me keep the end goal in sight. 
I also wish to thank my sister, Marsha Ward, her family, and 
my friends for their moral support. The combined efforts of 
these people have motivated me to complete this study and 
the graduate program. 
iii 
TABLE OF CONTENTS 
Chapter Page 
I. 
II. 
III. 
INTRODUCTION 1 
Current Status of Caffeine • . • • . 1 
Properties of the Drug . . . . • . . 7 
Effects of Caffeine . • . . 11 
Purpose of the study • • • • . . • • . . 13 
Hypotheses • • • • • . • 13 
Delimitations . . • • • • • • • . . . . . . 14 
Limitation . . • • • • • • . . . • . • • 15 
Assumptions • • • • • • • • • . . • • . 15 
LITERATURE REVIEW • 16 
Introduction . • • • . • . . • • • . . . 16 
Biological Effects of Caffeine • . • . . . . 16 
Effects of Caffeine on Movement Time 
and Reaction Time ..•••...•... 17 
Effects of Caffeine on Hand Steadiness 
and Manual Dexterity . • • . . . • . . 18 
summary • • • . • • . • • • . . • • • . . . 19 
METHODS 
Subjects • • • . • • • • 
Preliminary Procedures • 
Equipment and Testing Procedures 
Post-Procedure • • • • • • 
• 21 
21 
. 22 
• 22 
. 25 
IV. RESULTS AND DISCUSSION • • 26 
Results . . . . . . . . . . . . . . . . 26 
Hypotheses • . . . • • . . . 2 6 
Discussion of Results • . . . • . . 29 
Analysis of Variance . . . . . . . . 31 
Mean Times and Standard Deviations • . . 34 
V. SUMMARY, CONCLUSIONS, AND RECOMMENDATIONS FOR 
FURTHER STUDY . • . . • • . • • . . . . . 3 7 
summary • • • • • • • • • 
Conclusions • • • . • • 
Recommendations • . • . . 
iv 
• • 37 
• 37 
• 38 
Page 
REFERENCES . • • 40 
APPENDIXES . . • 44 
APPENDIX A - INDIVIDUAL'S CONSENT FOR PARTICI-
PATION IN A RESEARCH PROJECT . . 45 
APPENDIX B - MEDICAL HISTORY AND CAFFEINE 
CONSUMPTION QUESTIONNAIRE . . 49 
APPENDIX C - MEDICAL HISTORY UPDATE 51 
APPENDIX D - INSTRUCTIONS FOR TESTING • • . 53 
APPENDIX E - RAW DATA RECORD SHEET . . . . . . . . 55 
APPENDIX F - POST-TEST RAW DATA SCORES 57 
v 
LIST OF TABLES 
Table 
I. Caffeine Content in Beverages, Drugs, etc .• 
Page 
4 
II. Analysis of Variance ..•..•........ 31 
III. Mean Times ± Standard Deviations • . 
LIST OF FIGURES 
Figure 
1. Chemical Structure of Caffeine 
2. Half-life of Plasma Caffeine Levels 
vi 
0 0 • 34 
Page 
9 
0 10 
CHAPTER I 
INTRODUCTION 
Current Status of Caffeine 
Caffeine, a methylxanthine, can be found in virtually 
every individual's diet today. It is currently the most 
wide-spread and indiscriminately used drug available to 
consumers of all ages. This creates a need for more re-
search regarding the potential health risks and deleterious 
effects encountered by consumers of caffeine. 
The earliest study of the influence of caffeine in 
metabolism was carried out in 1850 {1). Few investigations 
of caffeine occurred prior to the 1970s, but a growth in 
scientific interest in the drug resulted from a draft issued 
by a special committee on drugs generally recognized as safe 
by the Food and Drug Administration (FDA) of the u.s. Public 
Health Service {2). 
Caffeine can be found as an ingredient in coffee, soft 
drinks, tea, chocolate, gelatines, puddings, frozen dairy 
products, baked goods, and over the counter as well as 
prescription medications (1). According to the FDA, about 
1000 prescription drug products and about 2000 OTC (nonpre-
scription) drug products contain caffeine (3). Typical 
prescription drugs contain on the order of 30-100 mg. 
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caffeine per tablet or capsule. Caffeine levels in OTC 
drugs also vary widely (typically from 15 to 200 mg. per 
tablet or capsule) and depend not only on the type of 
product, but also on the brand involved (4) (Table I). Many 
Americans are aware that the majority of soft drinks on the 
market today contain caffeine (Table I). Consequently 
several companies have developed "caffeine-free" soft 
drinks. Unfortunately the products still lack popularity 
with the consumers. The caffeine-free products accounted 
for 4.1% of the total soft drink market in 1986, a decline 
from the 4.7% share it represented in 1985 (43). 
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As a result of the indiscriminate use of caffeine as an 
ingredient in many products, most Americans are not aware of 
the amount of caffeine they consume in their diet. Accord-
ing to the Market Research Corporation of America Survey the 
mean daily caffeine intake for adults (18 years of age and 
above) is 2.6 milligrams per kilogram of body weight (mg.j-
kg. bwt.). The mean estimated intake among the heaviest 10% 
of adult consumers has been calculated from the MRCA data to 
be 7.0 mg.jkg. bwt. (5). According to another source the 
average daily consumption of caffeine in the u.s. is esti-
mated to be 206 mg. per person (6). 
A need exists for research regarding the effects of 
caffeine on hand steadiness, tracing ability, kinesthetic 
sense, and manual dexterity. Many occupations today demand 
precision and the performance of simple motor skills. If 
caffeine should affect these demands employees as well as 
employers have the right to know this information. 
3 
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TABLE I 
CAFFEINE CONTENT OF SOFT DRINKS (MG. CAFFEINE IN 12 OZ.) 
Source* 
Brand _1 _ _ 2 _ _ 3 _ _ 4_ 
Sugar Free Mr. Pibb 58.8 58.0 
Mountain Dew 54.0 54.0 54.7 49.0 
Mellow Yellow 52.8 52.0 
TAB 46.8 46.0 49.4 45.0 
Coca-Cola (old and new) 45.6 46.0 64.7 42.0 
Diet Coke 44.4 46.0 
Shasta cola 44.4 44.0 
Shasta Cherry Cola 44.4 44.0 
Shasta Diet Cola 40.8 44.0 
Mr. Pibb 40.8 40.8 57.0 
Dr. Pepper 39.6 40.8 60.9 61.0 
Sugar Free Dr. Pepper 39.6 40.8 54.2 
Big Red 38.4 30.8 
Sugar Free Big Red 38.4 
Pepsi-Cola 38.4 38.4 43.1 35.0 
Diet Pepsi 36.0 36.0 34.0 
RC Cola 36.0 36.0 33.7 36.0 
Diet Rite 36.0 31.7 
Diet RC 33.0 
*Source 
1. Institute of Food Technologists (IFT), April 
1983, based on data from National Soft Drink Asso-
ciation, Washington, D.C. 
2. Soft Drink Companies 
3. Bunker, L. and McWilliams, M. (1979). "Caffeine 
Content of Common Beverages." Journal of The 
American Dietetic Association, 74: 28-32. 
4. Soft Drink Companies and the Journal of the Ameri-
can Dietetic Association. 
TABLE I (Continued) 
CAFFEINE CONTENT IN COFFEE (MG. IN 5 OZ.) 
1 
Source* 
2 
5 
3 
Brewed, drip method 
Brewed, percolator 
Instant 
60-180 
40-170 
30-120 
150 
110 
66 
4.5 
2 
40-170 
Decaffeinated, brewed 
Decaffeinated, instant 
*Source 
2-5 
1-5 
1. FDA, Food Additive Chemistry Evaluation Branch. 
2. Journal of the American Dietetic Association. 
30-120 
3. FDA, Food Additive Chemistry Branch, based on evalua-
tions of existing literature on caffeine levels. 
CAFFEINE CONTENT IN TEA (MG. IN 5 OZ.) 
Brewed 
Iced (12 oz.) 
Instant 
*Source 
*Source 
1 
20-90 
67-76 
25-50 
1. FDA, Food Additive Chemistry Evaluation Branch. 
2. Journal of the American Dietetic Association. 
CAFFEINE CONTENT IN NON-PRESCRIPTION DRUGS 
2 
45 
45 
*Source 
Weight-Control Aids (capsule/tablet) 
Codex in 
Dexatrim 
Dietac 
Prolamine 
*Source 
Mg. Caffeine 
200 
200 
200 
140 
1. FDA's National Center for Drugs and Biologics. 
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TABLE I (Continued) 
CAFFEINE CONTENT IN NON-PRESCRIPTION DRUGS CONT. 
Pain Relievers (capsule/tablet) 
Anacin 
Excedrin 
Midol 
Vanquish 
Dristan 
Duradyne 
Cold & Allergy Remedies (capsule/tablet) 
Coryban-D capsules 
Triaminicin tablets 
Diuretics 
Aqua-Ban 
Aqua-Ban Plus 
*Source 
*Source 
Mg. Caff. 
32.0 
65.0 
32.4 
33.0 
16.2 
15.0 
Mg. Caff. 
30 
30 
Mg. Caff. 
100 
200 
Physician's Desk Reference and Pharmaceutical Companies. 
Alertness Tablets (tablet/capsule) 
*Source 
Nodoz 
Vivarin 
Caffedrine 
FDA's National Center for Drugs and Biologics. 
CAFFEINE CONTENT IN MISC. PRODUCTS 
Cocoa (5 oz.) 
Chocolate Milk (8 oz.) 
Milk Chocolate (1 oz.) 
Semi-sweet Choc. (1 oz.) 
Choc. flavored syrup (1 oz.) 
*Source 
FDA, Food Additive Chemistry Evaluation Branch. 
*Source 
Mg. Caff. 
100 
200 
200 
*Source 
Mg. Caffeine 
2-20 
2-7 
1-15 
5-35 
4 
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Properties of the Drug 
In order for an individual to have an understanding of 
the effects of caffeine on hand steadiness, tracing ability, 
kinesthetic sense, and manual dexterity one must possess 
general knowledge of the chemical make-up of the drug and 
caffeine's effects on the various systems within the body. 
Caffeine is a xanthine derivative. Pure caffeine is a 
white, odorless powder with a bitter taste. Sublimed 
crystals are hexagonal prisms, and crystals from saturated 
aqueous solutions are long, silky white needles which mat 
together rapidly (7). Caffeine is structurally identified 
as 1,3,7-trimethylxanthine {Figure 1). Caffeine forms 
relatively stable combinations with sodium benzoate and 
sodium salicylate, which are used in oral and intramuscular 
medicinal applications, and is decomposed by hot alkalies 
and reacts with chlorine (7) . The majority of neuropharma-
cological information on caffeine is limited to effects 
related to formation and release of neurotransmitters {8) 
specifically the catecholamines in the autonomic nervous 
system. 
Caffeine empties rapidly from the stomach and is ab-
sorbed from the gastrointestinal tract {9). The drug readi-
ly passes the blood brain barrier {10) and directly acts on 
the vagal, medullary, and vasomotor centers. It is absorbed 
by all organs and tissues in proportion to the water content 
of the organelle (9). Peak blood concentration occurs 
approximately 45-60 minutes after ingestion (42). Half-life 
of caffeine has been reported to extend from two to four 
hours (11) and may be affected by hormone interaction. For 
example, oral contraceptives taken in conjunction with 
caffeine increases the half-life threefold (12). However, 
tobacco use has been found to significantly decrease caf-
feine's plasma half-life (13) (Figure 2). 
Caffeine serves to stimulate the central nervous sys-
tem, cardiac muscles, kidneys, and certain glands (42). 
Additional reported physiological responses may include 
effects of the adenosine receptors by inhibition of enzyme 
activity (14). 
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HJCN------c~c~~\ 
o/c~N------c~~ 
CH3 
Figure 1. Chemical Structure of Caffeine 
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Individual 
Adult 
Child (6-10 yrs.) 
Infant 
premature and newborn 
7-9 months 
Pregnant Woman 
1 to 3 months 
4 to 9 months 
one week after birth 
Oral Contraceptive User 
Smoker 
Hours 
5-6 
2-3 
98 
4 
6 
10-18 
6 
12 
3.5 
Figure 2. Half-life of Plasma Caffeine 
Levels* (In Individuals) 
*The amount of time caffeine stays in 
the blood stream. 
Source: Sanford Miller and Jane Harris, 
FDA in "Don't Get Jittery Over 
Caffeine," Denise Grady. Discover. 
July, 1986. 
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Effects of Caffeine 
Caffeine serves as a stimulant to the Central Nervous 
System (CNS). Although distribution of ingested caffeine is 
dependent on the water content of the tissue and the 
response is proportional to the concentration, tolerance to 
caffeine by habitual users may alter the response (15). 
Additionally, some subjects may inherently be more or less 
sensitive to caffeine. Even small amounts of caffeine may 
alter blood pressure, heart rate, respiration and metabolic 
rate (16). Caffeine also causes blood vessels in the brain 
to constrict, while those in the extremities and around the 
heart dialate (17). Loss of hand steadiness, trembling, 
tremors, and chronic muscle tension have been causually 
observed in some investigations as undesired physical side 
effects of caffeine consumption. 
More research is being conducted in an effort to inves-
tigate the long-term effects of the use of caffeine. Pres-
ently long-term use is being scrutinized as the cause for 
peptic ulcers, painful (though benign) breast lumps, cancer, 
heart disease, and birth defects (17). However, the 
American Cancer Society denies any accusations linking 
caffeine to any form of cancer in human beings. This is 
difficult for researchers to study and prove as it requires 
a long-term investigation and must take many variables into 
account. 
Research also suggests possible associations to coro-
nary disease, arrhythmias, and elevated cholesterol (18). 
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Lethal doses of caffeine have been reported at 5,000 mg. to 
10,000 mg. (17). 
The relationship between caffeine and birth defects is 
of interest to every expectant mother. such a correlation 
has been suggested. Jacobson (19) reported that 23.2 
percent of mothers who gave birth to abnormal babies drank 
eight or more cups of coffee per day. Other studies are 
presently in progress or being planned and until more infor-
mation is available the FDA recommends pregnant women avoid 
caffeine-containing products or use them sparingly. Nursing 
mothers should also use caffeine products sparingly. Con-
centrations in breast milk often rise above those in the 
mother's blood and may make a nursing infant wakeful and 
cranky (17). 
One of the most noticeable effects of caffeine on 
humans is the stimulant effect. This effect was explained 
by a group led by Solomon snyder (17) at Johns Hopkins 
School of Medicine in 1981. They concluded caffeine has 
similar molecular structure to that of adenosine which is a 
chemical in the body with many properties, including the 
ability to act as a sedative. Adenosine locks on to special 
receptor molecules on brain cells, thus reducing the cells' 
activity. Caffeine also has the capability of attaching to 
these molecules, preventing adenosine from doing so. Conse-
quently the cells keep firing and a stimulant effect is 
experienced. snyder and his colleagues (17) also found that 
the body has more than one kind of adenosine receptor, that 
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the receptors are distributed differently in various 
tissues, and that caffeine can combine with all types -
hence its ability to affect so many systems. It has been 
suggested by many caffeine researchers the drug affects hand 
steadiness, simple motor skills, and reaction time. Caf-
feine has also been accused of inducing tremors. These 
findings have prompted other researchers to investigate 
caffeine's useful properties. 
Purpose of the Study 
The intent of this investigation was to examine the 
effects of two levels of caffeine (2.5 mg.jkg. bwt, and 5.0 
mg.jkg. bwt.) and a placebo containing lactose powder on 
hand steadiness, tracing, kinesthetic sense, and manual 
dexterity. 
Hypotheses 
The following hypotheses were examined in this investi-
gation: 
HOl: There will be no difference between the placebo 
and two levels of caffeine post-tests on hand steadiness 
time (HST) after consumption of placebo, 2.5 mg.jkg. bwt. 
and 5.0 mg.jkg. bwt. caffeine. 
H02: There will be no difference between the placebo 
and two levels of caffeine post-tests on hand steadiness 
count (HSC) after consumption of placebo, 2.5 mg.jkg. bwt. 
and 5.0 mg.jkg. bwt. caffeine. 
H03: There will be no difference between the placebo 
and two levels of caffeine post-tests on tracing time (TT) 
after consumption of placebo, 2.5 mg.jkg. bwt. and 5.0 
mg.jkg. bwt. caffeine. 
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H04: There will be no difference between the placebo 
and two levels of caffeine post-tests on tracing off time 
(TOF) after consumption of placebo, 2.5 mg.jkg. bwt. and 5.0 
mg.jkg. bwt. caffeine. 
H05: There will be no difference between the placebo 
and two levels of caffeine post-tests on tracing count after 
consumption of placebo, 2.5 mg.jkg. bwt and 5.0 mg./kg. bwt. 
caffeine. 
H06: There will be no difference between the placebo 
and two levels of caffeine post-tests on the kinesthesiome-
ter testing kinesthetic sense after consumption of placebo, 
2.5 mg.jkg. bwt. and 5.0 mg.jkg. bwt. caffeine. 
H07: There will be no difference between the placebo 
and two levels of caffeine post-tests on finger tip dexter-
ity and speed capacity 'of simple but rapid coordinated 
movement after consumption of placebo, 2.5 mg./kg. bwt. and 
5.0 mg.jkg. bwt. caffeine. 
Delimitations 
1. There were eight subjects used in this 
investigation. 
2. All subjects were healthy female college students 
from Oklahoma State University. 
3. There were two levels of caffeine administered, 
2.5 mg./kg. bwt. and 5.0 mg./kg. bwt. 
4. The subjects for this investigation were not 
randomly selected. 
5. All subjects were below the national average in 
amount of caffeine consumed per day (206 mg.). 
Limitation 
1. There may be individual sensitivity to caffeine. 
Assumptions 
1. Subjects correctly followed all instructions. 
2. Subjects consumed all caffeine with tap water. 
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3. Subjects were honest in their initial estimates of 
caffeine ingestion prior to the study. 
CHAPTER II 
LITERATURE REVIEW 
Introduction 
Caffeine has become a topic of current interest as an 
ergogenic agent, thus enhancing performance. Research 
regarding the drug's effect on endurance, movement and 
reaction time and muscular strength has resulted in equivo-
cal conclusions. The speculative physical effect of caf-
feine has prompted th~ International Olympic Committee and 
the National Collegiate Athletic Association of the U.S. to 
adopt bans on the use of caffeine to aid sport performance. 
Doses equivalent to 500-600 mg. caffeine or five to six cups 
of coffee within a one to two hour period are currently 
prohibitive (1). 
Biological Effects of Caffeine 
Contemporary research suggests that caffeine may pro-
long endurance events lasting one hour or more (20) (21) but 
does not aid in short exhaustive bouts of exercise (22). 
Recent evidence by Jacobson and Edgley (23) also suggests 
that moderate doses of caffeine reduces movement time and 
reaction time but higher doses may attenuate these effects. 
Although caffeine is known to affect the membrane integrity 
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of the sarcoplasmic reticulum (24) and to influence calcium 
engineering in the muscle (11) no contemporary data exists 
indicating that caffeine may increase voluntary muscular 
strength in either isometric or isotonic activity (25) . It 
has also been suggested that caffeine restores performance 
only when it has been impaired by fatigue, or otherwise 
degraded (26) (27). 
Doses of caffeine representative of the amount found in 
servings of food have been found to have behavioral effects 
on humans (28). In the same study it was found that doses 
of caffeine equivalent to amounts present in a 12 oz. serv-
ing of many cola beverages, over-the-counter analgesics, and 
one or two cups of coffee or tea, significantly improve 
auditory and visual vigilance (28). 
Effects of Caffeine on Movement 
Time and Reaction Time 
Research on the effects of caffeine on movement time 
and reaction time date back to 1912. However, the results 
are inconsistent. Hollingsworth (29) reported 65-130 mg. 
caffeine improved typing speed, and that a dose of 390 mg. 
resulted in poor motor performance and tremor. Jacobson and 
Edgley (23) found a significant improvement in both reaction 
time and movement time after a dose of 300 mg. caffeine but 
no considerable change after 600 mg. They suggested the 
neuromuscular system may reach a saturation level of the 
drug agent which may serve to prohibit further positive 
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effects, thus a dose response curve may be in effect. A 
study by Wenzel and Rutledge (30) which investigated the 
effects of 100-300 mg. doses of caffeine found dose-related 
improvement on simple reaction time and inverse relation-
ships on complex reaction time. Thornton (31) reported 
faster reaction times after a 300 mg. dose of caffeine. 
Switzer (32) documented that moderately large doses of 
caffeine stimulated associative performance, reaction time, 
and mental activity. Carpenter (33) suggests that caffeine 
produces small reductions in reaction time when there is a 
high intensity stimulation and high alcohol dose. Cheney 
(34) in early investigations of caffeine found that a dose 
of 3-5 mg.jkg. bwt. resulted in a varied reaction time 
effect and that a dose of 5 mg./kg. bwt. always decreased 
reaction time for up to a 3 hour period. In yet another 
study Cheney (35) found that 3.3-3.6 mg./kg. bwt. reduced 
discriminatory reaction time and reported no visible effect 
on color discrimination, mental decision, or precision 
reaction time unless the dose exceeded 3.0 mg./kg. bwt. 
Effects of Caffeine on Hand Steadiness 
and Manual Dexterity 
A possible correlation between hand steadiness and the 
consumption of caffeine has intrigued researchers for many 
years. However, the results of such studies have conflict-
ing conclusions. Some researchers have suggested that caf-
feine impairs hand steadiness and causes tremor (36) (41). 
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However, Wharrad et. al. (37) indicated no finger tremor as 
a result of 150 mg. caffeine taken three times daily in 
conjunction with a normal diet. Furthermore, Goldstein, 
Kaizer, and Warren (38} found no impairment of coordination 
as a result of 150 mg. and 300 mg. caffeine. Koller, Cone, 
and Herbster (39) studied 50 subjects without neurologic 
disease and reported that caffeine does not induce tremor in 
most normal individuals. However, they also suggested fine 
motor performance may be worsened by caffeine. 
Hollingsworth (40}, who was commissioned by the Coca-
Cola Company to study the influence of caffeine on mental 
and motor efficiency devised nine double-blind tests. He 
found beneficial motor and mental effects from 65 to 130 mg. 
caffeine, and tremor, poor motor performance, and insomnia 
caused by 390 mg. caffeine. Many investigations of hand 
steadiness involve the use of a hand held stylus which is 
placed in a hole for an allotted amount of time. smith, 
Tong, and Leigh (41} used such an instrument after their 
subjects ingested 200 mg. of "wake up" pills dissolved 
overnight in orange juice. They concluded that hand steadi-
ness was significantly impaired by caffeine. 
Summary 
Currently there is a lack of research regarding the 
dose response curve and its effect on hand steadiness. Any 
research in this area would be beneficial to all caffeine 
investigators. The results of investigations regarding the 
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effects of caffeine on reaction time, movement time, hand 
steadiness, and manual dexterity are inconsistent. The 
inconsistencies could be attributed to many variables 
including individual sensitivity to caffeine, differences in 
experimental protocol, and differences in dose administra-
tion. 
CHAPTER III 
METHODS 
Subjects 
This investigation consisted of eight healthy volunteer 
female subjects, all of whom were undergraduate students at 
Oklahoma State University, Stillwater, Oklahoma. The 
subjects were chosen on the basis of availability. They do 
not represent a sample of a stratified group within the 
population. They were not chosen from a particular class or 
organization. The mean age of the subjects was ±21.1 years 
old and the mean weight was t58.0 kg. All subjects were 
informed of the nature and the procedures of the experiment, 
including any possible risks or side effects that might be 
encountered. Each subject voluntarily signed an informed 
consent document as stipulated and approved by the Institu-
tional Review Board at Oklahoma State University (Appendix 
A). The subjects then completed a medical history question-
naire (Appendix B) which included questions pertaining to 
pregnancy, high blood pressure, intestinal disorders, 
cardiac or vascular disorders, and current medication. The 
subjects were also orally screened for any of these symp-
toms. If any of these symptoms were indicated by a subject 
21 
22 
prior to testing, they were eliminated from the study. 
Following the medical history questionnaire, each subject 
completed a caffeine consumption questionnaire (Appendix B). 
Preliminary Procedures 
Prior to testing the subjects were asked to fast from 
food a minimum of 5 hours and fast from caffeine a minimum 
of 48 hours. Following an explanation of the experiment and 
the completion of the necessary documents the subjects' 
heart rate and blood pressure were taken. Next, the sub-
jects' were randomly assigned either a placebo or a caffeine 
dosage; 2.5 mg.jkg. bwt. or 5.0 mg.jkg. bwt. The subjects' 
body weight, which was determined by oral inquiry, was used 
to ascertain the amount of caffeine that would be adminis-
tered. Prior to each pre-test session each subject was 
orally screened to determine if they were experiencing a 
lack of sleep, high level of stress, or pre-menstrual syn-
drome. If a subject answered "yes" to any of the above 
questions they were given the opportunity to reschedule the 
test session. 
Equipment and Testing Procedure 
The study used a double-blind, placebo controlled 
format. Neither the subject nor the principal investigator 
had knowledge of which dose was ingested. Subjects were 
randomly assigned to dose administrations and testing 
stations. Prior to the ingestion of either the placebo or a 
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caffeine dose, each subject was pre-tested on the following 
testing apparatus: 1) Lafayette model 32001 Steadiness 
Tester (hole type) for hand steadiness, 2) tracing pattern 
interfaced with a timer for hand steadiness, 3) kinesthesi-
ometer used in conjunction with opaque goggles which served 
as a blinder for kinesthetic sense, and 4) O'Connor Dexteri-
ty tweezer-pin placement apparatus test for finger-tip 
dexterity and speed capacity of simple but rapid coordinated 
movement. When subjects were tested for hand steadiness two 
variables were recorded. The first was hand steadiness time 
(HST) which was the amount of time during a 60 second test 
the subject was in contact with the plate, which was not 
desirable. The second variable was hand steadiness count 
(HSC), which was the number of times during the 60 second 
period the subject contacted or touched the plate with the 
stylus. 
When the subjects were tested for tracing ability three 
variables were recorded. The first, total tracing time (TT) 
was the amount of time it took the subject to trace the 
pattern from start to finish. The second variable tested 
was tracing off time (TOF) which was the amount of time the 
subject was not in contact with the pattern. The third 
variable was tracing count (TC) which indicated the number 
of times the subject was not in contact with the pattern. 
When subjects were tested for kinesthetic sense (K) the 
value recorded represents the difference between what the 
correct angular position previously placed by the 
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investigator and the angular placement by the subject in 
trying to duplicate the investigator's placement. The 
movement performed was shoulder rotation. The value which 
represents manual dexterity (D) was derived from the amount 
of time it took the subject to complete three rows of the 
tweezer-pin placement apparatus. 
The testing order was established in a random design. 
Subjects were given verbal instructions for task completion 
by the investigator and two trials were recorded at each 
station (Appendix D). 
Subsequent to each pre-test the subjects were given an 
oral dose of either a placebo or 2.5 mg.jkg. bwt. or 5.0 
mg.jkg. bwt. caffeine. The placebo consisted of a capsule 
containing lactose powder. Both the placebo and caffeine 
doses were administered with approximately 100 ml. cold tap 
water. Immediately following the ingestion of caffeine, the 
time was recorded so re-testing could be performed no less 
than one hour after ingestion. During the one hour waiting 
period subjects were asked to relax and refrain from any 
strenuous activities. 
Testing was performed in a quiet, isolated room in an 
attempt to avoid any outside visual or auditory interfer-
ence. All testing was performed in the Exercise Physiology 
lab on the campus of Oklahoma State University. All caf-
feine and placebo products were prepared by a local pharma-
cist. Pre- and post-test measurements were recorded for 
each one of the three product administrations (Appendix E). 
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This figure was derived by calculating the average of the 
two pre-test scores and calculating the average of the two 
post-test scores. This process of averaging scores was 
performed on all pre-tests and post-tests on each testing 
apparatus (Appendix F). Testing sessions were scheduled one 
week apart at identical times for each subject. 
Post-Procedure 
Immediately following the post-test session each sub-
ject was asked to complete a perceived ingestion question to 
ascertain the amount of caffeine they believed they had 
consumed. The time for each session was approximately 1.5 
hours. The total time for all sessions was approximately 
4.5 hours. Subjects were encouraged to eat immediately 
after the testing but were asked to refrain from eating 
spicy foods. Any subject who encountered any ill feelings 
was asked to contact the principal investigator immediately. 
CHAPTER IV 
RESULTS AND DISCUSSION 
Results 
This investigation involved the testing of seven 
hypotheses for significance at the .05 level. A hypothesis 
for each of the following was tested: hand steadiness time, 
hand steadiness count, tracing time, tracing off time, 
tracing count, kinesthetic sense, and manual dexterity. The 
hypotheses were examined to see if a difference occurred 
between post-tests when 0 mg./kg. bwt., 2.5 mg.jkg. bwt., 
and 5.0 mg.jkg. bwt. caffeine was ingested. 
Hypothesis 1 
The first hypothesis stated there would be no differ-
ence between the placebo and two levels of caffeine post-
tests on hand steadiness time after consumption of placebo, 
2.5 mg.jkg. bwt. and 5.0 mg.jkg. bwt. caffeine. 
Hypothesis 2 
The second hypothesis stated there would be no differ-
ence between the placebo and two levels of caffeine post-
tests on hand steadiness count after consumption of placebo, 
2.5 mg./kg. bwt. and 5.0 mg.jkg. bwt. caffeine. 
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Hypothesis 3 
The third hypothesis stated there would be no differ-
ence between the placebo and two levels of caffeine post-
tests on tracing time after consumption of placebo, 2.5 
mg.jkg. bwt. and 5.0 mg./kg. bwt. caffeine. 
Hypothesis 4 
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The fourth hypothesis stated there would be no differ-
ence between the placebo and two levels of caffeine post-
tests on tracing off time after consumption of placebo, 2.5 
mg.jkg. bwt. and 5.0 mg.jkg. bwt. caffeine. 
Hypothesis 5 
The fifth hypothesis stated there would be no differ-
ence between the placebo and two levels of caffeine post-
tests on tracing count after consumption of placebo, 2.5 
mg.jkg. bwt. and 5.0 mg.jkg. bwt. caffeine. 
Hypothesis 6 
The sixth hypothesis stated there would be no differ-
ence between the placebo and two levels of caffeine post-
tests on the kinesthesiometer testing kinesthetic sense 
after consumption of placebo, 2.5 mg.jkg. bwt. and 5.0 
mg.jkg. bwt. caffeine. 
Hypothesis 7 
The seventh hypothesis stated there would be no 
difference between the placebo and two levels of caffeine 
post- tests on finger tip dexterity and speed capacity of 
simple but rapid coordinated movement after consumption of 
placebo, 2.5 mg.jkg. bwt. and 5.0 mg./kg. bwt. caffeine. 
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The mean and standard deviation for each variable can 
be found in Table III. A repeated measures analysis of 
variance was used in analyz.ing the pre~test data. No 
significance (p>0.05) was found for any variable in the 
pre-test. A repeated measures analysis of variance was also 
used in analyzing post-test data and a significant differ-
ence (p<0.05) was detected on four occasions (Tables II and 
III). By administering the Newman-Kuels post-hoc procedure 
on all post-test data a -significance (p<0.05) was found 
between post-tests on hand steadiness time after 5.0 mg./kg. 
bwt. caffeine was ingested. Therefore, the first hypothesis 
was rejected. A significant difference was also detected 
between the caffeine and placebo on hand steadiness count 
after 2.5 mg./kg. bwt. and 5.0 mg.jkg. bwt. caffeine was 
ingested. This caused the second hypothesis to be rejected. 
The third hypothesis was accepted when no significance 
was detected between post-tests on tracing time. Likewise, 
the fourth hypothesis was also accepted when no significance 
was found between post-tests on tracing off time. A signif-
icant difference was detected between post-tests on tracing 
count after 5.0 mg.jkg. bwt. was ingested. Therefore, the 
fifth hypothesis was rejected. 
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No significant difference was found between post-tests 
on the kinesthesiometer which was used to measure kinesthet-
ic sense. As a result the sixth hypothesis was accepted. 
Finally, a significance was found between post-tests on 
manual dexterity after 5.0 mg./kg. bwt. caffeine was 
ingested. Consequently, the seventh hypothesis was 
rejected. 
When subjects were given the placebo the majority 
perceived to have ingested 0 mg.jkg. bwt. caffeine. When 
the subjects ingested 2.5 mg.jkg. bwt. caffeine (small dose) 
the majority perceived they had ingested a moderate amount. 
Finally, when the subjects received a moderate dose of 5.0 
mg.jkg. bwt. caffeine they perceived to have ingested a 
large dose. In conclusion, the author suggests when the 
subjects received a caffeine dose (not including placebo) 
they perceived it to be higher than what it actually was. 
Discussion of Results 
Based on the results of this experiment hand steadiness 
is impaired after 2.5 mg.jkg. bwt. caffeine. Also 5.0 
mg.jkg. bwt. caffeine impairs hand steadiness, tracing 
ability, and finger tip dexterity and speed capacity of 
simple but rapid coordinated movement. For a 120 lb. person 
this would be equivalent to two to three cups of coffee. 
For a 180 lb. person this would be the equivalent of four to 
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six cups of coffee. This should be of particular concern to 
those individuals who maintain occupations requiring fine 
motor performance (surgeon, dentist, key punch operator, 
etc.) 
The results of this experiment are consistent with the 
findings of many other studies. However, it is difficult to 
compare the results of this study to previous studies 
because the dosage of caffeine was given according to the 
subject's body weight (not a blanket dose which is often 
performed in caffeine research). Also all subjects were 
female and below the national average for caffeine consump-
tion per day. Subjects were asked to fast from caffeine and 
food prior to testing. The author does not have knowledge 
if these variables were considered in previous studies, 
therefore making it difficult to make a comparison. 
Source 
TABLE II 
ANALYSIS OF VARIANCE 
HAND STEADINESS TIME 
Post Test 
Sum of 
Squares 
Mean of 
D.F. Squares 
Between Groups*1224.08128 
Within Groups 196.90070 
1 
2 
1224.08128 
98.45035 
Source 
HAND STEADINESS COUNT 
Post Test 
Sum of 
Squares 
Mean of 
D.F. Squares 
F 
Ratio 
31 
F 
Prob. 
100.90 0.0000 
7.21 0.0070 
F 
Ratio 
F 
Prob. 
Between Groups 165668.16667 1 165668.16667 92.10 
Within Groups 12683.08333 2 6341.54167 7.59 
0.0000 
0.0059 
TRACING TIME 
Post Test 
Sum of Mean of F F 
Source Squares D. F. Squares Ratio Prob. 
Between Groups 18216.05484 1 18216.05484 30.55 0.0009 
Within Groups 188.49270 2 94.24635 2.14 0.1545 
*Groups refer to levels of dosage (0, 2.5 and 5.0 mg.jkg. 
bwt. caffeine. 
Source 
TABLE II (Continued) 
TRACING OFF TIME 
Post Test 
Sum of 
Squares D. F. 
Mean of 
Squares 
Between Groups 502.33493 
Within Groups 24.89251 
1 
2 
502.33493 
12.44625 
TRACING COUNT 
Post Test 
Sum of Mean of 
Source Squares D. F. Squares 
Between Groups 15708.16667 1 15708.16667 
Within Groups 604.58333 2 320.29167 
KINESTHETIC SENSE 
Post Test 
sum of Mean of 
source Squares D. F. Squares 
Between Groups 3408.16667 1 3408.16667 
Within Groups 5.58333 2 2.79167 
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F F 
Ratio Prob. 
33.19 0.0007 
2.12 0.1547 
F F 
Ratio Prob. 
70.95 0.0001 
4.92 0.0241 
F F 
Ratio Prob. 
81.94 0.0000 
0.10 0.9055 
Source 
TABLE II (Continued) 
MANUAL DEXTERITY 
Post Test 
Sum of 
Squares D. F. 
Mean of 
Squares 
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F F 
Ratio Prob. 
Between Groups 258690.34444 
Within Groups 2489.97405 
1 
2 
258690.34444 347.43 0.0000 
1244.98703 5.46 0.0177 
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TABLE III 
MEAN TIMES ± STANDARD DEVIATIONS 
OF VARIABLES 
Group 
1. 0 mg .jkg. bwt 
2. 2.5 mg.jkg. bwt. 
3. 5.0 mg.jkg. bwt. 
HAND STEADINESS TIME 
Post Test 
3.70 
7.01 
10.71 
HAND STEADINESS COUNT 
Group 
1. o mg.jkg. bwt. 
2. 2.5 mg.jkg. bwt. 
3. 5.0 mg.jkg. bwt. 
Group 
1. 0 mg./kg. bwt. 
2. 2.5 mg.jkg. bwt. 
3. 5.0 mg./kg. bwt. 
Post Test 
52.00 
90.38 
106.88 
TRACING TIME 
Post Test 
23.90 
28.04 
30.71 
Standard Deviation 
±2.05 
±3.06 
±5.08* 
Standard Deviation 
±21. 90 
±32.47* 
±44.01* 
Standard Deviation 
±12.90 
±15.41 
±16.75 
*Denotes statistically significant difference. 
TABLE III (Continued) 
Group 
1. 0 mg.jkg. bwt. 
2. 2.5 mg.jkg. bwt. 
3. 5.0 mg.jkg. bwt. 
Group 
1. o mg.jkg. bwt. 
2. 2.5 mg.jkg. bwt. 
3. 5.0 mg.jkg. bwt. 
Group 
1. o mg.jkg. bwt. 
2. 2.5 mg.jkg. bwt. 
3. 5.0 mg.jkg. bwt. 
TRACING OFF TIME 
Post Test 
3.63 
4.11 
5.99 
TRACING COUNT 
Post Test 
20.38 
23.75 
32.63 
KINESTHETIC SENSE 
Post Test 
11.25 
12.38 
12.13 
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Standard Deviation 
±1. 96 
±1.66 
±4.50 
Standard Deviation 
±6.50 
±7.94 
±15.69* 
Standard Deviation 
±5.70 
±7.07 
±3.87 
TABLE III (Continued) 
Group 
1. 0 mg.jkg. bwt. 
2. 2.5 mg.jkg. bwt. 
3. 5.0 mg.jkg. bwt. 
MANUAL DEXTERITY 
Post Test 
92.49 
101.79 
117.19 
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Standard Deviation 
±12.40 
±13.93 
±29.20* 
CHAPTER V 
SUMMARY, CONCLUSIONS, AND RECOMMENDATIONS 
FOR FURTHER STUDY 
Summary 
Eight female undergraduate students were tested for the 
effects selected doses of caffeine have on hand steadiness, 
tracing ability, kinesthetic sense, and manual dexterity. 
Each subject was tested three times and was given either 0 
mg.jkg. bwt., 2.5 mg.jkg. bwt., or 5.0 mg.jkg. bwt. caffeine 
randomly. A different dose was administered each time the 
subject was tested. Subjects were administered a pre-test 
before each ingestion. Approximately 60 minutes after the 
ingestion of either the pl~cebo or caffeine dose a post-test 
was administered. 
Conclusions 
This study which tested the effects of selected doses 
of caffeine suggests four conclusions. The first conclusion 
is hand steadiness time is impaired at 5.0 mg.jkg. bwt. 
caffeine but not at 2.5 mg.jkg. bwt. The second conclusion 
suggests that hand steadiness count is impaired at the 2.5 
and 5.0 mg.jkg. bwt. caffeine levels. The third conclusion 
is tracing count is impaired at the 5.0 mg./kg. bwt. 
37 
caffeine levels. Finally, the fourth conclusion suggests 
manual dexterity becomes impaired at the 5.0 mg.jkg. bwt. 
caffeine level but not at 2.5 mg.jkg. bwt. These findings 
and conclusions should be of importance to the general 
public and in particular, people who maintain occupations 
that require and demand hand steadiness and fine motor 
performance. Some occupations which would be affected by 
the loss of hand steadiness or manual dexterity include 
microsurgeons, computer chip technicians, laser technolo-
gists, key punch operators, etc. 
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The long-term effect of caffeine on children is of 
interest to many researchers. When conducting research with 
children it is imperitive to be aware of their body weight. 
For example, for a 30 lb. (13.6 kg.) child it would only 
take approximately 1.5 cokes before hand steadiness and fine 
motor coordination would be impaired. Parents should be 
aware of the amount of caffeine their children are consuming 
on both a short and long term basis. 
Recommendations for Further Study 
In an attempt to further study the effects of selected 
doses of caffeine the author suggests using more subjects 
and adding at least one more dosage of caffeine (higher than 
5.0 mg.jkg. bwt.) in an attempt to identify a dose response 
curve andjor the saturation level in the subjects. Another 
investigation which would be of benefit to the realm of 
caffeine research would involve the testing of subjects on a 
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full stomach after the ingestion of coffee. This investiga-
tion would attempt to determine if the deleterious effects 
of caffeine are avoided, decreased, or delayed as a result 
of a full stomach. 
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APPENDIX A 
INDIVIDUAL'S CONSENT FOR 
PARTICIPATION IN A 
RESEARCH PROJECT 
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Individual's Consent for Participation in a Research Project 
OKLAHOMA STATE UNIVERSITY 
I, , voluntarily agree to participate in 
this study entitled: The Effects of Selected Doses of 
Caffeine on Hand Steadiness, Manual Dexterity, Fine Motor 
Coordination, Kinesthetic Se~se, and Perceived Ingestion. 
1. PURPOSE: This study involves research that will be 
carried out under the supervision of Bert H. Jacobson, Ed.D. 
and Krista Winter. The purpose of this study will be to 
ascertain the effects of 2.5 mg.jkg. bwt. and 5.0 mg.jkg. 
bwt. caffeine on hand steadiness, manual dexterity, fine 
motor coordination, kinesthetic sense, and perceived 
ingestion. Such qualities are often necessary andjor vital 
for occupations today. Given that one cup of coffee 
contains 100 mg. caffeine, it is safe to assume that many 
professionals consume up to 400 mg. caffeine prior to or 
during work time. However, casual consumption is not all in 
one dose. This study will attempt to find if deleterious 
effects follow a single dose of 2.5 mg.jkg. bwt. and 5.0 
mg.jkg. bwt. caffeine consumption. 
2. STATUS OF INVESTIGATIONAL DRUG PROCEDURES: Caffeine may 
alter blood pressure, heart rate, respiration and metabolic 
rate. Caffeine may also induce tremors, nervousness, and 
anxiety. 
3. DESCRIPTION OF STUDY: This study will involve a pre-
screening consisting of blood pressure and heart rate. 
Additionally a medical history questionnaire containing the 
following items will be administered: oral contraceptive 
use, medication use, current illnesses, pregnancy, hang over 
and history of heart disease. Further, a caffeine 
consumption questionnaire will be administered to ascertain 
the average amount of caffeine consumed per day and week. 
Any subject indicating a blood pressure reading above 140 
mm. Hg. systolic pressure andjor 60 rom. Hg. diastolic 
pressure andjor tachycardia will be eliminated from the 
study. Also, any positive response on the medical history 
questionnaire will result in elimination. 
Subjects will be asked to fast from food for 5 hours 
and fast from caffeine for 48 hours prior to testing. 
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Subjects will be pre-tested for hand steadiness, manual 
dexterity, fine motor coordination, and kinesthetic sense. 
Following the pre-test, each subject will be given one of 
three solutions containing 1) 0 mg. caffeine, 2) 2.5 mg./kg. 
bwt. or 3) 5.0 mg.jkg. bwt. caffeine on a double blind 
format. Following a one (1) hour waiting period, all 
subjects will be post-tested using the pre-test protocol. 
The full duration of this study will take approximately one 
and a half (1.5) hours. 
I understand that I will be given 0 mg., 2.5 mg.jkg. 
bwt. and 5.0 mg.jkg. bwt. caffeine. Neither I nor the 
investigator will know which dosage I have been administered 
during each test but that information can be obtained if 
necessary. 
4. BENEFITS: No direct benefit in the consumption of 
caffeine may be expected. However, observable physical 
changes may lead to a change in attitude toward caffeine 
consumption and a greater awareness of products containing 
caffeine may ensue. 
5. POSSIBLE RISKS: Caffeine ingestion in the quantities 
described in this study may increase nervousness, 
irritability and anxiety. Respiration, blood pressure and 
heart rate may also be magnified. Additionally, nausea may 
appear if the meal following caffeine consumption includes 
spicy and/or greasy food. STAY AWAY FROM PIZZA. If you 
become nauseous or feel ill, you will be retained for 
observation and transported to the University Health Center. 
I recognize that the primary risk is the possibility of 
experiencing some side effects. Those that have been 
observed in the past for caffeine consumption include: 
Hyperactivity 
Upset stomach after eating pizza 
If I have any side-effects, I will report them 
immediately to the investigator, my physician or hisjher 
associates. If side-effects are severe, I may be removed 
from the study. 
6. ALTERNATE PROCEDURES: None 
7. SUBJECT ASSURANCES: Whereas no assurance can be made 
concerning results that may be obtained (because results 
from investigational studies cannot be predicted with 
certainty), the principal investigator will take every 
precaution consistent with best scientific practice. 
By signing this consent form, I acknowledge that my 
participation in this study is voluntary. I also 
acknowledge that I have not waived any of my legal rights or 
released this institution from liability for negligence. 
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I may revoke my consent and withdraw from this study at 
any time without penalty or loss of benefits. My treatment 
by, and relations with the investigators and staff at 
Oklahoma State University, now and in the future, will not 
be affected in any way if I refuse to participate, or if I 
enter the program and later withdraw. 
Records of this study will be kept confidential with 
respect to any written or verbal reports making it 
impossible to identify me individually. All records will be 
held in a locked file belonging to the PI. 
If I have any questions about my rights as a research 
subject, I may take them to the Office of University 
Research Services, 001 Life Sciences East. Phone: 744-
9991. 
8. SIGNATURES: 
Date Research Subject 
Date Witness 
Date Principal Investigator 
Any questions regarding the research may be addressed 
to Bert Jacobson, 102 Colvin Center. Phone: 744-5493. 
Subjects will receive a copy of this consent form following 
the study. 
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CAFFEINE RESEARCH QUESTIONNAIRE 
Caffeine Consumption History 
Vital Statistics 
Medical History 
Name. __________________ __ Age. __ _ Weight. ____ _ 
Pre HR: -------- Pre BP: ___ _ 
Caffeine Consumption History 
Coffee: Cups/day avg. 
Height. ____ _ 
Soft Drinks (Coke, Pepsi, Diet Coke, etc.)jday __ _ 
avg. 
Tea: Cupsjday __ _ Glasses/day __ __ 
Other: explain ____________________________________________ _ 
How does caffeine affect you? ____________________________ __ 
Medical History 
Have you ever experienced or 
Heart trouble 
Intestinal disorders 
High heart rate 
know of:--' 
Stomach disorders 
High Blood Press. 
Mental/Emotion. dis. ___ _ 
Are you presently on medication? If so explain 
Are you suffering from a hangover? __ _ 
Do you think you are pregnant? ___ _ 
Are you currently taking oral contraceptives? ___ _ 
Are you currently suffering from lack of sleep? ___ _ 
Have you fasted for five hours? __ _ 
Last meal was hrs. ago. 
Last caffeine was consumed hrs. ago in the form of 
Time of ingestion, __________ _ 
Time of testing 
Group 
50 
APPENDIX C 
CAFFEINE RESEARCH QUESTIONNAIRE UPDATE 
51 
CAFFEINE RESEARCH QUESTIONNAIRE UPDATE 
Caffeine Consumption Update 
Vital Statistics 
Medical Update 
Name __________________________ _ Session. ________________________ _ 
Pre HR~----------------------- Pre BP 
Post HR ______________________ _ Post HR. ________________________ _ 
1. Are you presently on medication? If so, what? __________ __ 
2. Are you suffering from a hangover? ______ _ 
3. Do you think you are pregnant?~-----
4. Are you taking oral contraceptives? ____ __ 
5. Are you suffering from lack of sleep? ______ _ 
6. Are you currently experiencing a high level of stress? 
If so, would you prefer to reschedule this session? ____ _ 
7. Are you currently experiencing PMS? If so, would 
you like to reschedule this session? ____ __ 
8. Have you suffered an illness since your previous test 
session?(flu, cold, etc.)If so, what? ______ _ 
9. Has your average caffeine consumption per day changed 
since your previous test session? If so, what is 
it? ____ __ 
Have you fasted from food for five hours? ____ __ 
Your last meal was hours ago? 
Your last caffeine was consumed 
of 
Time of ingestion __________ _ 
Time of testing __________ _ 
Group __________ _ 
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INSTRUCTIONS FOR TESTING 
INSTRUCTIONS FOR HAND STEADINESS 
1. Hold stylus like you would a pencil. 
2. Do not rest fingers or arm on table or brace arm 
against your body in any way. 
3. Hold tip of stylus in hole which has two black stripes 
above it. 
4. You will perform this test for 60 seconds. 
INSTRUCTIONS FOR TRACING 
1. Hold stylus as you would a pencil. 
2. Do not rest or brace fingers or arm on table. 
3. Trace the pattern on the board, working from the bottom 
of the pattern to the top. 
INSTRUCTIONS FOR KINESTHESIOMETER 
1. Place right arm in the tray. 
2. Grasp knob with little finger. 
3. Close your eyes. 
4. The tester will move your arm to a designated spot and 
back to the point of origin. 
5. With your eyes closed you will attempt to move your arm 
to the exact the tester did and stop at that position. 
INSTRUCTIONS FOR MANUAL DEXTERITY 
1. Hold tweezer' in a comfortable position. 
2. Using the tweezer, pick up a pin from the bowl and 
place it in the first row, first hole on the left side. 
3. Work left to right. When you complete the first row 
move to the second and complete it as you did the 
first. 
4. Complete the designated number of rows as quickly as 
possible. 
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RAW DATA RECORD SHEET 
Name ________________________ __ 
PRE 
Hand Steadiness (60 sec) 
Time Count 
1. 
2. 
Total Time 
Tracing 
Off Time Count 
1. 
2. 
Kinesthesiometer 
1. (45) 
2. (30) 
3. (60) 
O'Connor Dexterity 
1. 
2. 
Session --------------------
POST 
Hand Steadiness (60 sec) 
Time Count 
1. 
2. 
Tracing 
Total Time Off Time Count 
1. 
2. 
Kinesthesiometer 
1. (45) 
2. (30) 
3. (60) 
O'Connor Dexterity 
1. 
2. 
Perceived Ingestion 
None Small Moderate Large 
0 10 
Place an "x" at the point you feel most indicates your 
perception of caffeine ingestion. 
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POST-TEST RAW DATA 
0.0 mg.jkg. bwt. caffeine 
Subject HST HSC TT TOF TC K D 
01 01.5 023 07.7 00.9 13 15 079.9 
02 02.5 056 19.8 01.3 13 17 092.5 
03 03.6 049 22.9 03.1 26 13 088.5 
04 07.2 093 08.9 05.8 19 06 111.1 
05 02.0 033 30.7 04.6 25 12 100.9 
06 05.6 064 21.1 02.7 20 11 081.8 
08 05.1 061 33.6 06.2 31 16 079.0 
10 02.1 037 46.5 04.4 16 00 106.2 
2.5 mg.jkg. bwt. caffeine 
01 05.8 080 05.9 01.9 12 25 092.9 
02 04.1 053 22.1 01.9 14 12 108.2 
03 07.6 114 23.9 04.6 29 11 095.3 
04 09.7 118 10.4 03.6 21 01 117.3 
05 05.5 075 36.1 05.4 31 07 110.8 
06 12.9 146 36.0 06.4 33 17 085.8 
08 06.8 080 52.3 05.5 29 15 084.4 
10 03.7 057 37.6 03.6 21 11 119.6 
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POST-TEST DATA CONT. 
5. o mg.jkg. bwt. caffeine 
Subject HST HSC TT TOF TC K D 
01 13.1 141 08.3 01.4 22 15 118.5 
. 
02 16.6 133 23.0 04.5 35 07 111.5 
03 06.7 091 44.7 09.0 44 13 159.0 
04 12.3 179 11.0 04.2 21 19 119.2 
05 17.1 083 40.5 14.6 63 10 151.7 
06 05.9 073 23.5 03.0 22 13 075.5 
08 10.9 115 55.0 09.0 38 12 081.9 
10 03.1 040 39.7 02.2 16 08 120.2 
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